ATHA Athira Pharma Inc: Sof marja

Athira Pharma Inc (ATHA) - korporativ logo

Athira Pharma, Inc. (ATHA) ning neyron aloqalarini regeneratsiya qilishdagi innovatsiyalari sof marja dinamikasi bilan bog'liq bo'lib, bunda 0.00 ko'rsatkichi samaradorlik holatini belgilaydi. Altsgeymer kasalligiga qarshi yo'naltirilgan kichik molekulalarning kengayishi bozorni egallashni maqsad qilgan, biroq yagona yo'nalishga kritik bog'liqlik biznesni yashab qolish uchun restrukturizatsiyadan o'tishga majbur qilmoqda. Ushbu savdo marjasi grafigi kompaniyaning fundamental tendentsiyasidagi uzilishni o'z vaqtida aniqlash imkonini beradi.

Athira Pharma Corp (ATHA) Sof foyda bo'yicha sotuv rentabelligi: 04.07.2022 - 12.01.2026 davri uchun

Athira (ATHA) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- aksiya kursi va ekspertlarning narx prognozi:
Kompaniyaning barcha koʻrsatkichlari tahlili:Athira Pharma, Inc.
Athira Pharma Inc tayyor mahsulotlari

Ishonchli aksiyadorlik aktivlarini tanlash daromadni sof foydaga aylantirish samaradorligini tahlil qilishdan boshlanadi. Ushbu ko'rsatkich sof foydaning umumiy savdoga nisbati sifatida hisoblanadi va biznesning yakuniy daromadliligini o'lchaydi. Neyrodegeneratsiyani o'rganuvchi Athira Pharma, Inc. (ATHA) laboratoriyalarining barqaror faoliyati ushbu jarayonlarning operatsion xarajatlariga bevosita ta'sir ko'rsatadi. Uskunalarning ish vaqti to'xtab qolmasligi xarajatlarni minimallashtirib, moliyaviy natijani barqarorlashtiradi. Savdo marjasi tendentsiyasi ushbu modelning chidamliligini tasdiqlaydi.

Muhim raqobatchilar

BIIB: Sotuvning sof marjinal rentabelligi|Sof marja Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Sotuvning sof marjinal rentabelligi|AXSM: Sof foyda normasi|Sof marja acadia-pharm.com (ACAD)|Sotuvning sof marjinal rentabelligi Xenon Pharmaceuticals (XENE)|Sof marja Viking Therapeutics VKTX|Sof foyda normasi SUPN|CPRX - Sof marja|Sof marja Denali Therapeutics|HRMY: Sotuvning sof marjinal rentabelligi|Biohaven - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi AMLX|Trevi Therapeutics, Inc. (TRVI) - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi PRAX (Praxis Medicines)|Anavex Corp - Sotuvning sof rentabelligi|Sof marja CeriBell CBLL|Kompaniya sotuv marjasi Prothena Biosciences (PRTA)|ALEC: Sof foyda bo'yicha sotuv rentabelligi|ANNX - Sotuvning sof marjinal rentabelligi|Omeros Corp. (OMER) - Sof marja|Sof marja Neurogene Inc. (NGNE)|Sof foyda bo'yicha sotuv rentabelligi ACIU|Sof marja VYGR|Sof marja Neumora (NMRA)|SCLX - Sof marja|Sotuvning sof marjinal rentabelligi TVGN (Tevogen Bio Holdings Inc.)|Sof foyda normasi ACOG|Cognition Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|IKT - Sotuvning sof marjinal rentabelligi|SAVA: Sotuvning sof marjinal rentabelligi|Assertio Holdings, Inc. - Sof foyda normasi|COYA (Coya) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi VTGN (Vistagen Therapeutics)|Sof marja Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning sof rentabelligi|Sof marja CervoMed, Inc. CRVO|Sotuvning sof marjinal rentabelligi Alterity Therapeutics ATHE|CLNN: Sof foyda bo'yicha sotuv rentabelligi|PEPG (pepgen.com) - Sotuvning sof rentabelligi|Jupiter Neurosciences Inc (JUNS) - Sof marja|Relmada Therapeutics - Sof foyda normasi|ANVS (Annovis Bio Inc) - Sotuvning sof marjinal rentabelligi|GRCE: Sof foyda normasi|Sof marja Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Sof foyda normasi|Sof marja neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Sof marja|MTVA: Sof foyda bo'yicha sotuv rentabelligi|NeurAxis, Inc (NRXS) - Sof foyda bo'yicha sotuv rentabelligi|HSDT: Sotuvning sof marjinal rentabelligi|PASG - Kompaniya sotuv marjasi|Sof marja Neuphoria Therapeutics, Inc.|Sof marja NERV|Sof marja Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi CYCN (cyclerion.com)|Sof foyda bo'yicha marjinallik Protagenic|KTTA: Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi CRGT (cortigent.com)|ATXI: Sotuvning sof marjinal rentabelligi|BCLI (BrainStorm Cell Therapeutics) - Sof marja|CARA (Cara Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sof marja CHRO|Sof foyda bo'yicha sotuv rentabelligi ELYM (Eliem Therapeutics)|Sof marja ITCI (Intra-Cellular Therapies Inc.)|Sotuvning sof marjinal rentabelligi LBPH (Longboard Pharma)|Sotuvning sof marjinal rentabelligi Marinus Pharmaceuticals Inc MRNS|NKGen Biotech Corp - Sotuvning sof marjinal rentabelligi|Sof foyda normasi NRBO (NeuroBo Pharma)|SAGE (Sage Therapeutics, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi SNPX|Sof foyda bo'yicha sotuv rentabelligi TRVN|Sof marja VIGL|Sotuvning sof marjinal rentabelligi WENA|Kompaniya sotuv marjasi Cerevel